KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Gilead Sciences (GILD) Shares Outstanding (Weighted Average) (2016 - 2025)

Gilead Sciences' Shares Outstanding (Weighted Average) history spans 17 years, with the latest figure at $1.2 billion for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) changed 0.24% year-over-year to $1.2 billion; the TTM value through Dec 2025 reached $1.2 billion, changed 0.24%, while the annual FY2025 figure was $1.2 billion, 0.24% changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $1.2 billion in Q4 2025 per GILD's latest filing, roughly flat from $1.2 billion in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $1.3 billion in Q1 2021 to a low of $1.2 billion in Q4 2025.
  • Average Shares Outstanding (Weighted Average) over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2023.
  • Peak YoY movement for Shares Outstanding (Weighted Average): increased 0.08% in 2021, then fell 0.56% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $1.3 billion in 2021, then fell by 0.08% to $1.3 billion in 2022, then dropped by 0.56% to $1.2 billion in 2023, then dropped by 0.08% to $1.2 billion in 2024, then fell by 0.24% to $1.2 billion in 2025.
  • Per Business Quant, the three most recent readings for GILD's Shares Outstanding (Weighted Average) are $1.2 billion (Q4 2025), $1.2 billion (Q3 2025), and $1.2 billion (Q2 2025).